VISTA, CA – Aug 9, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only,...
Come visit Leica Biosystems at the 5th Digital Pathology & AI Congress: USA booth #13 and learn more about our Imaging Solutions portfolio in hardware and software.
VISTA, CA –May 29, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for clinical diagnosis in the...
VISTA, CA – January 7th, 2019 – Leica Biosystems, the global leader in pathology workflow solutions announced today that the US Patent Office has granted it a patent for RTF, its breakthrough “Real-Time Focusing” technology (US patent 9,841,590)....
Register Now for On Demand
Abstract:
Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the analysis of target protein expression in subsets of specific cells within the context of...
NEWCASTLE, ENGLAND, UK NOVEMBER 2018 – Leica Biosystems, a leading provider of pathology products and solutions, globally launched a new PD-L1 antibody for use on their fully automated BOND IHC and ISH staining platform.
The new PD-L1 (programmed...
Melbourne, Australia and Cambridge, Massachusetts – September 14, 2018 | Leica Biosystems and Ultivue begin Co-Marketing of UltiMapper™ Assay on the BOND RX enabling single-step automated multiplexing in under 6 hours.
Building on its legacy of...
Collaboration to enable large-scale transition from glass slides to digital images for pathology diagnoses across all subspecialties
VISTA, Calif.—Oct. 11, 2018— Leica Biosystems the cancer diagnostics leader achieved a major digital pathology...
New from Leica Biosystems, first integrated specimen containment and transport system promises to enhance efficiency and diagnostic confidence.
RICHMOND, Ill.— October 2, 2018 — Leica Biosystems, the leader in cancer diagnostics from biopsy to...